Clover Health Investments, Corp.
CLOV
$3.14
$0.010.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 456.91M | 330.68M | 322.58M | 349.90M | 341.72M |
| Total Other Revenue | 5.43M | 6.28M | 8.41M | 6.36M | 4.73M |
| Total Revenue | 462.33M | 336.96M | 330.99M | 356.26M | 346.46M |
| Cost of Revenue | 353.44M | 243.04M | 249.77M | 248.35M | 265.16M |
| Gross Profit | 108.89M | 93.92M | 81.21M | 107.91M | 81.29M |
| SG&A Expenses | 109.70M | 115.02M | 90.20M | 99.92M | 103.79M |
| Depreciation & Amortization | 466.00K | 344.00K | 339.00K | 330.00K | 318.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 463.61M | 358.41M | 340.31M | 348.60M | 369.27M |
| Operating Income | -1.27M | -21.45M | -9.32M | 7.66M | -22.82M |
| Income Before Tax | -1.27M | -21.48M | -8.79M | 7.17M | -23.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.27M | -21.48M | -8.79M | 7.17M | -23.17M |
| Earnings from Discontinued Operations | -- | -611.00K | -370.00K | 238.00K | 4.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.27M | -22.09M | -9.16M | 7.41M | -19.17M |
| EBIT | -1.27M | -21.45M | -9.32M | 7.66M | -22.82M |
| EBITDA | -808.00K | -21.10M | -8.98M | 7.99M | -22.50M |
| EPS Basic | 0.00 | -0.04 | -0.02 | 0.02 | -0.04 |
| Normalized Basic EPS | 0.00 | -0.03 | -0.01 | 0.01 | -0.03 |
| EPS Diluted | 0.00 | -0.05 | -0.02 | 0.01 | -0.04 |
| Normalized Diluted EPS | 0.00 | -0.03 | -0.01 | 0.01 | -0.03 |
| Average Basic Shares Outstanding | 497.06M | 491.87M | 490.18M | 487.48M | 486.37M |
| Average Diluted Shares Outstanding | 497.06M | 491.87M | 490.18M | 495.18M | 486.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |